Dr. Kraus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Research Triangle Park
2 Davis Drive
Durham, NC 27709Phone+1 347-334-2687
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1999 - 2002
University of ChicagoResidency, Internal Medicine, 1995 - 1999
Washington University in St. Louis School of MedicineClass of 1995
Certifications & Licensure
NC State Medical License 2009 - 2025
MD State Medical License 1999 - 2014
IL State Medical License 1995 - 1999
Publications & Presentations
PubMed
- 5 citationsQuantitation of a Novel Engineered Anti-infective Host Defense Peptide, ARV-1502: Pharmacokinetic Study of Different Doses in Rats and Dogs.Alexandra Brakel, Daniela Volke, Carl N. Kraus, Laszlo Otvos, Ralf Hoffmann
Frontiers in Chemistry. 2019-11-13 - 17 citationsSafety and Pharmacokinetics of a Four Monoclonal Antibody Combination Against Botulinum C and D Neurotoxins.Doris M Snow, Kathryn Riling, Angie Kimbler, Yero Espinoza, David Wong
Antimicrobial Agents and Chemotherapy. 2019-10-07 - 8 citationsEfficacy of ARV-1502, a Proline-Rich Antimicrobial Peptide, in a Murine Model of Bacteremia Caused by Multi-Drug Resistant (MDR) Acinetobacter baumannii .Yan Q. Xiong, Liang Li, Yu-Feng Zhou, Carl N Kraus
Molecules. 2019-08-02
Press Mentions
Arrevus Gets Support from NC Biotech Center to Advance ARV-1801 for Pulmonary Exacerbations in CFNovember 4th, 2019
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
